Dr. rer. nat. Natalie Taege

Natalie Taege works as postdoctoral researcher at the Institute for Experimental Endocrinology. Her research focuses on androgen (signalling) deficiency and its molecular effects on metabolism. In 2024, Natalie received her PhD as part of the research training group Adipocyte Brain Crosstalk at the University of Lübeck. In her dissertation, she investigated the fat-depot and adipocyte-specific epigenetic regulation of leptin gene expression in leanness and obesity. She performed her studies in Molecular Life Science at the University of Lübeck from 2014 – 2020. Natalie’s research interest lies in the field of metabolism, specifically in obesity and epigenetics, and the dysregulation of hormones arising from metabolic complications.

Publikationen

Stephan, D.*, Taege, N.*, Dore, R., Folberth, J., Jöhren, O., Schwaninger, M., ... & Schulz, C. (2022). Knockdown of Endogenous Nucb2/Nesfatin-1 in the PVN Leads to Obese-Like Phenotype and Abolishes the Metformin-and Stress-Induced Thermogenic Response in Rats. Hormone and Metabolic Research, 54(11), 768-779., *shared first co-authors

Geißler, C., Krause, C., Neumann, A. M., Britsemmer, J. H., Taege, N., Grohs, M., ... & Kirchner, H. (2022). Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice. The Journal of Nutritional Biochemistry, 100, 108907.

Britsemmer, J. H., Krause, C., Taege, N., Geißler, C., Lopez-Alcantara, N., Schmidtke, L., ... & Kirchner, H. (2023). Fatty Acid Induced Hypermethylation in the Slc2a4 Gene in Visceral Adipose Tissue Is Associated to Insulin-Resistance and Obesity. International Journal of Molecular Sciences, 24(7), 6417.

Krause, C., Britsemmer, J. H., Bernecker, M., Molenaar, A., Taege, N., Lopez-Alcantara, N., ... & Kirchner, H. (2023). Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity. bioRxiv, 2023-10.

Lopez-Alcantara, N., Naujack, A. M., Chen, Y., Taege, N., Geißler, C., Oelkrug, R., ... & Mittag, J. (2025). Dysregulation of hepatic deiodinase type I in metabolically associated steatotic liver disease. Journal of Molecular Endocrinology, 75(2).